AI Verdict
MYCB has stronger fundamentals based on our AI analysis.
MYGN vs MYCB Fundamental Comparison
| Metric | MYGN | MYCB |
|---|---|---|
| Revenue | $824.5M | $0.0 |
| Net Income | $-365.9M | $-94,244.0 |
| Net Margin | -44.4% | N/A |
| ROE | -99.4% | N/A |
| ROA | -51.8% | -23.6% |
| Current Ratio | 2.49x | 0.87x |
| Debt/Equity | 0.33x | N/A |
| EPS | $-3.95 | $-0.01 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MYGN vs MYCB: Frequently Asked Questions
Is MYGN or MYCB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MYCB has stronger fundamentals. MYGN is rated STRONG SELL (87% confidence) while MYCB is rated STRONG SELL (95% confidence). This is not investment advice.
How does MYGN compare to MYCB fundamentally?
MYRIAD GENETICS INC has ROE of -99.4% vs My City Builders, Inc.'s N/A. Net margins are -44.4% vs N/A respectively.
Which stock pays higher dividends, MYGN or MYCB?
MYGN has a dividend yield of N/A or no dividend while MYCB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MYGN or MYCB for long term?
For long-term investing, consider that MYGN has STRONG SELL rating with 87% confidence, while MYCB has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MYGN vs MYCB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MYGN vs MYCB, the AI consensus favors MYCB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.